Revenue
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $11.1M | $7.4M | $10.1M | $5.7M | — |
| Research & development | $726,299 | $427,672 | $0 | $0 | — |
| Operating expenses | $25.6M | $18.1M | $7.1M | $2.7M | — |
| Operating income | −$14.5M | −$10.7M | $2.9M | $3.1M | — |
| Operating margin | −131.07% | −143.01% | 29.27% | 53.43% | — |
| EBITDA | −$14.4M | −$10.5M | $3.0M | $3.1M | — |
| EBITDA margin | −129.69% | −141.63% | 29.94% | 53.53% | — |
| Net income | −$15.2M | −$12.0M | $2.5M | $3.1M | — |
| Net profit margin | −136.72% | −160.68% | 24.83% | 53.68% | — |
| Basic EPSper basic share | -$0.31 | -$0.29 | $0.04 | $0.09 | -$0.03 |
| Diluted EPSper diluted share | -$0.31 | -$0.29 | $0.04 | $0.09 | -$0.03 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
ZHOU KAI | 40.98M |
WEN HUAXIN | 688.46K |
Rogers James Beeland Jr. | 220.75K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.